Korean J Urol.  2011 Apr;52(4):233-240.

Radical Cystectomy and Orthotopic Bladder Substitution Using Ileum

• Park J
• Ahn H

Abstract

Over the past decade, continent urinary diversion, especially orthotopic bladder substitutions, has become increasingly popular following radical cystectomy for bladder cancer. The ultimate goal of orthotopic bladder substitution is to offer patients the best quality of life, similar to that of patients with native bladders. To achieve that purpose, surgeons should be familiar with the characteristics of good candidates for neobladders, the possible intraoperative and postoperative problems related to the surgery, and the solutions to these problems. Postoperative surveillance and instructions given to the patients also contribute to successful, functional results. Here, we reviewed the indications, pitfalls, and solutions for orthotopic bladder substitutions and the patients' quality of life after surgery. When performed properly, orthotopic continent diversion offers good quality of life with few long-term complications. Therefore, we believe it is the best option for the majority of patients requiring cystectomy.

Keyword

Cystectomy; Quality of life; Urinary bladder; Urinary bladder neoplasms; Urinary diversion

MeSH Terms

Cystectomy
Humans
Ileum
Quality of Life
Urinary Bladder
Urinary Bladder Neoplasms
Urinary Diversion

Reference

1. Hautmann RE, de Petriconi R, Gottfried HW, Kleinschmidt K, Mattes R, Paiss T. The ileal neobladder: complications and functional results in 363 patients after 11 years of followup. J Urol. 1999. 161:422–427.

2. Studer UE, Zingg EJ. Ileal orthotopic bladder substitutes. What we have learned from 12 years' experience with 200 patients. Urol Clin North Am. 1997. 24:781–793.

3. Stein JP, Skinner DG. Application of the T-mechanism to an orthotopic (T-pouch) neobladder: a new era of urinary diversion. World J Urol. 2000. 18:315–323.

4. World Health Organization (WHO) Consensus Conference on Bladder Cancer. Hautmann RE, Abol-Enein H, Hafez K, Haro I, Mansson W, et al. Urinary diversion. Urology. 2007. 69:1 Suppl. 17–49.

5. Kristjánsson A, Davidsson T, Månsson W. Metabolic alterations at different levels of renal function following continent urinary diversion through colonic segments. J Urol. 1997. 157:2099–2103.

6. Skinner DG, Studer UE, Okada K, Aso Y, Hautmann H, Koontz W, et al. Which patients are suitable for continent diversion or bladder substitution following cystectomy or other definitive local treatment? Int J Urol. 1995. 2:Suppl 2. 105–112.

7. Studer UE, Hautmann RE, Hohenfellner M, Mills RD, Okada Y, Rowland RG, et al. Indications for continent diversion after cystectomy and factors affecting long-term results. Urol Oncol. 1998. 4:172–182.

8. Stenzl A, Draxl H, Posch B, Colleselli K, Falk M, Bartsch G. The risk of urethral tumors in female bladder cancer: Can the urethra be used for orthotopic reconstruction of the lower urinary tract? J Urol. 1995. 153:950–955.

9. Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol. 2005. 173:1163–1168.

10. Stein JP, Cote RJ, Freeman JA, Esrig D, Elmajian DA, Groshen S, et al. Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens. J Urol. 1995. 154:1329–1333.

11. Stein JP, Esrig D, Freeman JA, Grossfeld GD, Ginsberg DA, Cote RJ, et al. Prospective pathologic analysis of female cystectomy specimens: risk factors for orthotopic diversion in women. Urology. 1998. 51:951–955.

12. Herr HW, Donat SM. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol. 2001. 165:62–64.

13. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001. 19:666–675.

14. Hautmann RE, Simon J. Ileal neobladder and local recurrence of bladder cancer: patterns of failure and impact on function in men. J Urol. 1999. 162:1963–1966.

15. Chung MK, Seo HK. Urinary diversion: ileal conduit to orthotopic neobladder substitution. Korean J Urol. 2007. 48:565–573.

16. Leissner J, Hohenfellner R, Thüroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int. 2000. 85:817–823.

17. Wiesner C, Salzer A, Thomas C, Gellermann-Schultes C, Gillitzer R, Hampel C, et al. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int. 2009. 104:331–335.

18. Wright JL, Lin DW, Porter MP. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer. 2008. 112:2401–2408.

19. Park J, Park S, Song C, Doo C, Cho YM, Ahn H, et al. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy. Urology. 2007. 70:257–262.

20. Kristjánsson A, Mânsson W. Refluxing or nonrefluxing ureteric anastomosis. BJU Int. 1999. 84:905–910.

21. Studer UE, Danuser H, Thalmann GN, Springer JP, Turner WH. Antireflux nipples or afferent tubular segments in 70 patients with ileal low pressure bladder substitutes: long-term results of a prospective randomized trial. J Urol. 1996. 156:1913–1917.

22. Pantuck AJ, Han KR, Perrotti M, Weiss RE, Cummings KB. Ureteroenteric anastomosis in continent urinary diversion: long-term results and complications of direct versus nonrefluxing techniques. J Urol. 2000. 163:450–455.

23. Kristjansson A, Abol-Enein H, Alm P, Mokhtar AA, Ghoneim MA, Mànsson W. Long-term renal morphology and function following enterocystoplasty (refluxing or anti-reflux anastomosis): an experimental study. Br J Urol. 1996. 78:840–846.

24. Dybner R, Jeter K, Lattimer JK. Comparison of intraluminal pressures in ileal and colonic conduits in children. J Urol. 1972. 108:477–479.

25. Elder DD, Moisey CU, Rees RW. A long-term follow-up of the colonic conduit operation in children. Br J Urol. 1979. 51:462–465.

26. Berglund B, Kock NG. Volume capacity and pressure characteristics of various types of intestinal reservoirs. World J Surg. 1987. 11:798–803.

27. Thoeny HC, Sonnenschein MJ, Madersbacher S, Vock P, Studer UE. Is ileal orthotopic bladder substitution with an afferent tubular segment detrimental to the upper urinary tract in the long term? J Urol. 2002. 168:2030–2034.

28. Song C, Kang T, Hong JH, Kim CS, Ahn H. Changes in the upper urinary tract after radical cystectomy and urinary diversion: a comparison of antirefluxing and refluxing orthotopic bladder substitutes and the ileal conduit. J Urol. 2006. 175:185–189.

29. Min GE, Song C, Ahn H. Impact of vesico-ureteral reflux on renal function after a radical cystectomy: a comparison of refluxing and antirefluxing orthotopic bladder substitutes. Korean J Urol. 2007. 48:933–937.

30. Rawal S, Kumar P, Kaul R, Raghunath SK, Julka S. The 'pitcher pot' ileal neobladder: early experiences. Jpn J Clin Oncol. 2006. 36:717–722.

31. Chang SS, Baumgartner RG, Wells N, Cookson MS, Smith JA Jr. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting. J Urol. 2002. 167:208–211.

32. Chang SS, Cookson MS, Baumgartner RG, Wells N, Smith JA Jr. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol. 2002. 167:2012–2016.

33. Hollenbeck BK, Miller DC, Taub D, Dunn RL, Khuri SF, Henderson WG, et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol. 2005. 174:1231–1237.

34. Novotny V, Hakenberg OW, Wiessner D, Heberling U, Litz RJ, Oehlschlaeger S, et al. Perioperative complications of radical cystectomy in a contemporary series. Eur Urol. 2007. 51:397–401.

35. Park HK, Kwak C, Byun SS, Lee E, Lee SE. Early removal of nasogastric tube after cystectomy with urinary diversion: Does postoperative ileus risk increase? Urology. 2005. 65:905–908.

36. Resnick J, Greenwald DA, Brandt LJ. Delayed gastric emptying and postoperative ileus after nongastric abdominal surgery: part I. Am J Gastroenterol. 1997. 92:751–762.

37. Maffezzini M, Campodonico F, Canepa G, Gerbi G, Parodi D. Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus. Surg Oncol. 2008. 17:41–48.

38. Inman BA, Harel F, Tiguert R, Lacombe L, Fradet Y. Routine nasogastric tubes are not required following cystectomy with urinary diversion: a comparative analysis of 430 patients. J Urol. 2003. 170:1888–1891.

39. Cheatham ML, Chapman WC, Key SP, Sawyers JL. A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg. 1995. 221:469–476.

40. Vermeulen H, Storm-Versloot MN, Busch OR, Ubbink DT. Nasogastric intubation after abdominal surgery: a meta-analysis of recent literature. Arch Surg. 2006. 141:307–314.

41. Kouba EJ, Wallen EM, Pruthi RS. Gum chewing stimulates bowel motility in patients undergoing radical cystectomy with urinary diversion. Urology. 2007. 70:1053–1056.

42. Choi H, Kang SH, Yoon DK, Kang SG, Ko HY, Moon DG, et al. Chewing gum has a stimulatory effect on bowel motility in patients after open or robotic radical cystectomy for bladder cancer: a prospective randomized comparative study. Urology. 2010. Epub ahead of print.

43. Wood DP Jr, Bianco FJ Jr, Pontes JE, Heath MA, DaJusta D. Incidence and significance of positive urine cultures in patients with an orthotopic neobladder. J Urol. 2003. 169:2196–2199.

44. Wullt B, Holst E, Steven K, Carstensen J, Pedersen J, Gustafsson E, et al. Microbial flora in ileal and colonic neobladders. Eur Urol. 2004. 45:233–239.

45. Wullt B, Agace W, Mansson W. Bladder, bowel and bugs--bacteriuria in patients with intestinal urinary diversion. World J Urol. 2004. 22:186–195.

46. Varol C, Studer UE. Managing patients after an ileal orthotopic bladder substitution. BJU Int. 2004. 93:266–270.

47. Abol-Enein H, Ghoneim MA. Functional results of orthotopic ileal neobladder with serous-lined extramural ureteral reimplantation: experience with 450 patients. J Urol. 2001. 165:1427–1432.

48. Hautmann RE. Urinary diversion: ileal conduit to neobladder. J Urol. 2003. 169:834–842.

49. Light JK. Continence mechanisms following orthotopic bladder substitution. Scand J Urol Nephrol Suppl. 1992. 142:95–97.

50. Steers WD. Voiding dysfunction in the orthotopic neobladder. World J Urol. 2000. 18:330–337.

51. Steven K, Poulsen AL. The orthotopic Kock ileal neobladder: functional results, urodynamic features, complications and survival in 166 men. J Urol. 2000. 164:288–295.

52. Arai Y, Okubo K, Konami T, Kin S, Kanba T, Okabe T, et al. Voiding function of orthotopic ileal neobladder in women. Urology. 1999. 54:44–49.

53. Nesrallah LJ, Srougi M, Dall'Oglio MF. Orthotopic ileal neobladder: the influence of reservoir volume and configuration on urinary continence and emptying properties. BJU Int. 2004. 93:375–378.

54. Hugonnet CL, Danuser H, Springer JP, Studer UE. Urethral sensitivity and the impact on urinary continence in patients with an ileal bladder substitute after cystectomy. J Urol. 2001. 165:1502–1505.

55. Madersbacher S, Möhrle K, Burkhard F, Studer UE. Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. J Urol. 2002. 167:2052–2057.

56. Tchetgen MB, Sanda MG, Montie JE, Faerber GJ. Collagen injection for the treatment of incontinence after cystectomy and orthotopic neobladder reconstruction in women. J Urol. 2000. 163:212–214.

57. Ghoneim MA, Shaaban AA, Mahran MR, Kock NG. Further experience with the urethral Kock pouch. J Urol. 1992. 147:361–365.

58. El Bahnasawy MS, Osman Y, Gomha MA, Shaaban AA, Ashamallah A, Ghoneim MA. Nocturnal enuresis in men with an orthotopic ileal reservoir: urodynamic evaluation. J Urol. 2000. 164:10–13.

59. Studer UE, Danuser H, Hochreiter W, Springer JP, Turner WH, Zingg EJ. Summary of 10 years' experience with an ileal low-pressure bladder substitute combined with an afferent tubular isoperistaltic segment. World J Urol. 1996. 14:29–39.

60. Lee KS, Montie JE, Dunn RL, Lee CT. Hautmann and Studer orthotopic neobladders: a contemporary experience. J Urol. 2003. 169:2188–2191.

61. Stein JP, Lieskovsky G, Ginsberg DA, Bochner BH, Skinner DG. The T pouch: an orthotopic ileal neobladder incorporating a serosal lined ileal antireflux technique. J Urol. 1998. 159:1836–1842.

62. Smith E, Yoon J, Theodorescu D. Evaluation of urinary continence and voiding function: early results in men with neo-urethral modification of the Hautmann orthotopic neobladder. J Urol. 2001. 166:1346–1349.

63. Hautmann RE, Paiss T, de Petriconi R. The ileal neobladder in women: 9 years of experience with 18 patients. J Urol. 1996. 155:76–81.

64. Ghoneim MA. Orthotopic bladder substitution in women following cystectomy for bladder cancer. Urol Clin North Am. 1997. 24:225–239.

65. Mikuma N, Hirose T, Yokoo A, Tsukamoto T. Voiding dysfunction in ileal neobladder. J Urol. 1997. 158:1365–1368.

66. Shimogaki H, Okada H, Fujisawa M, Arakawa S, Kawabata G, Kamidono S, et al. Long-term experience with orthotopic reconstruction of the lower urinary tract in women. J Urol. 1999. 161:573–577.

67. Ali-el-Dein B, el-Sobky E, Hohenfellner M, Ghoneim MA. Orthotopic bladder substitution in women: functional evaluation. J Urol. 1999. 161:1875–1880.

68. Mills RD, Studer UE. Female orthotopic bladder substitution: a good operation in the right circumstances. J Urol. 2000. 163:1501–1504.

69. Stenzl A, Colleselli K, Poisel S, Feichtinger H, Bartsch G. The use of neobladders in women undergoing cystectomy for transitional-cell cancer. World J Urol. 1996. 14:15–21.

70. Cancrini A, De Carli P, Fattahi H, Pompeo V, Cantiani R, Von Heland M. Orthotopic ileal neobladder in female patients after radical cystectomy: 2-year experience. J Urol. 1995. 153:956–958.

71. Gillon G, Mundy AR. The dissolution of urinary mucus after cystoplasty. Br J Urol. 1989. 63:372–374.

72. Bushman W, Howards SS. The use of urea for dissolution of urinary mucus in urinary tract reconstruction. J Urol. 1994. 151:1036–1037.

73. Månsson W, Davidsson T, Könyves J, Liedberg F, Månsson A, Wullt B. Continent urinary tract reconstruction - the Lund experience. BJU Int. 2003. 92:271–276.

74. Leibovitch IJ, Ramon J, Chaim JB, Goldwasser B. Increased urinary mucus production: a sequela of cystography following enterocystoplasty. J Urol. 1991. 145:736–737.

75. Gatti R, Ferretti S, Bucci G, Simonazzi M, Cortellini P, Orlandini G. Histological adaptation of orthotopic ileal neobladder mucosa: 4-year follow-up of 30 patients. Eur Urol. 1999. 36:588–594.

76. Aragona F, De Caro R, Parenti A, Artibani W, Bassi P, Munari PF, et al. Structural and ultrastructural changes in ileal neobladder mucosa: a 7-year follow-up. Br J Urol. 1998. 81:55–61.

77. Haupt G, Pannek J, Knopf HJ, Schulze H, Senge T. Rupture of ileal neobladder due to urethral obstruction by mucous plug. J Urol. 1990. 144:740–741.

78. Benderev TV. Acetylcysteine for urinary tract mucolysis. J Urol. 1988. 139:353–354.

79. Mills RD, Studer UE. Metabolic consequences of continent urinary diversion. J Urol. 1999. 161:1057–1066.

80. Fosså SD, Heilo A, Børmer O. Unexpectedly high serum methotrexate levels in cystectomized bladder cancer patients with an ileal conduit treated with intermediate doses of the drug. J Urol. 1990. 143:498–501.

81. Bowyer GW, Davies TW. Methotrexate toxicity associated with an ileal conduit. Br J Urol. 1987. 60:592.

82. Sagalowsky AI, Frenkel EP. Cobalamin profiles in patients after urinary diversion. J Urol. 2002. 167:1696–1700.

83. Dutta SC, Chang SC, Coffey CS, Smith JA Jr, Jack G, Cookson MS. Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol. 2002. 168:164–167.

84. Autorino R, Quarto G, Di Lorenzo G, De Sio M, Perdonà S, Giannarini G, et al. Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder. Eur J Surg Oncol. 2009. 35:858–864.

85. Hara I, Miyake H, Hara S, Gotoh A, Nakamura I, Okada H, et al. Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement. BJU Int. 2002. 89:10–13.

86. Sogni F, Brausi M, Frea B, Martinengo C, Faggiano F, Tizzani A, et al. Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology. 2008. 71:919–923.

87. Hobisch A, Tosun K, Kinzl J, Kemmler G, Bartsch G, Höltl L, et al. Life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. Semin Urol Oncol. 2001. 19:18–23.

88. Somani BK, Gimlin D, Fayers P, N'Dow J. Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion--a prospective cohort study with a systematic review of literature. Urology. 2009. 74:1138–1143.

89. Porter MP, Penson DF. Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature. J Urol. 2005. 173:1318–1322.

90. Gerharz EW, Månsson A, Hunt S, Skinner EC, Månsson W. Quality of life after cystectomy and urinary diversion: an evidence based analysis. J Urol. 2005. 174:1729–1736.